1.93% -0.07

Vistagen Therapeutics Inc (VTGN)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Vistagen Therapeutics Inc Azioni (VTGN) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	1,727% 0.244	-0.015	0.234	0.183	0.084
Operating Expenses	10.83% 16.05	14.48	15.35	14.41	12.21
Benefits Costs and Expenses	12.62% 15.34	13.62	14.32	13.14	10.82
Costs And Expenses	12.62% 15.34	13.62	14.32	13.14	10.82
Operating Income/Loss	9.03% -15.80	-14.49	-15.12	-14.23	-12.13
Income/Loss From Continuing Operations Before Tax	10.71% -15.10	-13.63	-14.09	-12.95	-10.73
Income Tax Expense/Benefit	-	-	-	0.007	-
Income/Loss From Continuing Operations After Tax	10.71% -15.10	-13.63	-14.09	-12.96	-10.73
Net Income/Loss	10.71% -15.10	-13.63	-14.09	-12.96	-10.73
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	13,927% 31.93	0.2276	30.71	30.63	30.60
Diluted Average Shares	13,927% 31.93	0.2276	30.71	30.63	30.60
Basic Earnings Per Share	6.82% -0.47	-0.44	-0.46	-0.42	-0.35
Diluted Earnings Per Share	6.82% -0.47	-0.44	-0.46	-0.42	-0.35
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

INCY

$86.64

1.40%

GMAB

$27.54

0.58%

SMMT

$25.98

9.16%

BNTX

$112.46

8.66%

INSM

$145.10

1.80%

ONC

$341.80

7.24%